Reta 20 is a triple agonist. Retatrutide (Reta) selectively activates GLP‑1, GIP, and glucagon receptors, offering a potent multi-pathway approach for researching synergistic effects on obesity, glucose metabolism, and energy balance.
Details
- Quantity: 10mg per vial
- Contents: Freeze-dried Lyophilized powder (reconstitution required)
- Packaging: Glass vial sealed with a rubber stopper and a protective flip-off plastic cap
- Certificate of Analysis: Analytical Testing Report
Research: Phase 3 clinical trials
- Lipid and Glucose Balance: Investigated for influence on triglyceride storage, glucose regulation, and nutrient handling.
- Metabolic Function: Studied for combined effects on glucose metabolism, energy expenditure, and hormone regulation.
- Obesity Research: Examined for its role in multi‑receptor control of body weight and appetite.
- Endocrine Studies: Provides insight into synergistic signalling between GLP‑1, GIP, and glucagon receptors.
⚠️ Exclusive Research Use
All products are sold strictly for laboratory and research purposes only. Not for human consumption. By purchasing this product, you confirm that you are a qualified individual using it in accordance with all applicable laws and research regulations.
Reviews
There are no reviews yet.